Zainab Muneeb’s Post

A key benefit to sponsors is our diverse experience across multiple therapeutic areas, patient populations, and product types! Read more on Source Nutraceutical, Inc.'s latest blog post that features our team: #️⃣ #clinicaltrials #clinicalresearch #cosmetictesting #efficacytesting #pharmacokineticstudies #bioequivalencestudies #️⃣

Trial Equity's Clinical Trial Diversity training through Scout empowers sponsors and CROs to meet FDA diversity guidelines! Equip yourself with tools for strategic recruitment and retention. Click the 🔗 in the comments and lead the change! #DiversityInTrials #TrialEquity #ClinicalTrialDiversity

Human safety after administration of the new drug is the focus of Phase 1 clinical trials. Phase 1 clinical trial designs should answer key questions, including: https://lnkd.in/gpQ2z4UB #Phase1 #ClinicalTrial #ClinicalResearch

🌍 Clinical Trials Day 2024 🌍 🗓️ Tuesday, December 17, 2024, at 11:00 AM ET Join the discussion-what’s next in clinical trials. Excited to announce that Amy Abernethy, co-founder of Highlander Health and former FDA Principal Deputy Commissioner, will be headlining! With experience from the FDA to Silicon Valley, she’ll share insights on key trends reshaping our field. The talk will tackle some of drug development’s toughest challenges, like serving patients with rare diseases and leveraging real-world evidence to overcome regulatory hurdles. Don’t miss out on this important discussion! #ClinicalTrials #Biopharma #RealWorldEvidence

The clinical trial landscape is rapidly evolving, with new regulations increasing public disclosure requirements. Lawyers from Foley Hoag and Europe's HGF will provide multi-disciplinary insights on navigating these challenges in the U.S. and Europe.

The clinical trial landscape is rapidly evolving, with new regulations increasing public disclosure requirements. Lawyers from Foley Hoag and Europe's HGF will provide multi-disciplinary insights on navigating these challenges in the U.S. and Europe.

Comprehensive document of Designing Clinical Trials.

The clinical trial landscape is rapidly evolving, with new regulations increasing public disclosure requirements. Lawyers from Foley Hoag and Europe's HGF will provide multi-disciplinary insights on navigating these challenges in the U.S. and Europe.

The clinical trial landscape is rapidly evolving, with new regulations increasing public disclosure requirements. Lawyers from Foley Hoag and Europe's HGF will provide multi-disciplinary insights on navigating these challenges in the U.S. and Europe.

The clinical trial landscape is rapidly evolving, with new regulations increasing public disclosure requirements. Lawyers from Foley Hoag and Europe's HGF will provide multi-disciplinary insights on navigating these challenges in the U.S. and Europe.